NEW YORK (Reuters Health) – Placement of synthetic mesh to reinforce anterior vaginal prolapse repair is associated with improved anatomic outcomes at two years, a study shows. However,…
NEW YORK (Reuters Health) – For women in spontaneous labor but requiring labor augmentation, oral misoprostol is as effective as intravenous oxytocin, at team from the University of…
NEW YORK (Reuters Health) – Pulsatile rather than continuous infusion of oxytocin in women requiring induction of labor confers little benefit, and when used for labor augmentation it…
NEW YORK (Reuters Health) – Energy-based vessel sealing appears to decrease operating time, blood loss, and hospital stay in women undergoing vaginal hysterectomy, researchers say. “Energy-based vessel sealing…
NEW YORK (Reuters Health) – Women who deliver their first baby with a cesarean section face an increased risk of adverse reproductive outcomes in subsequent pregnancies, according to…
NEW YORK (Reuters Health) – All women found to have vulvar intraepithelial neoplasia (VIN) require some form of treatment and follow-up surveillance, according to recommendations from The American…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
NEW YORK (Reuters Health) – For the majority of women undergoing gynecologic surgery for benign conditions, intermittent pneumatic compression provides sufficient protection against venous thromboembolism (VTE). Women at…
NEW YORK (Reuters Health) – Women with familial hypercholesterolemia (FH) do not appear to be at increased risk of adverse pregnancy outcomes, Norwegian researchers report in a September…
NEW YORK (Reuters Health) – Women with pure menstrual migraines without aura will experience greater symptom relief with a combined oral contraceptive (COC) regimen that includes four placebo…